What is the generic name?

COAGULATION FACTOR VIIA RECOMBINANT HUMAN

What is the Trade Name for COAGULATION FACTOR VIIA RECOMBINANT HUMAN?

Sevenfact

What are the Indications for COAGULATION FACTOR VIIA RECOMBINANT HUMAN?

• 1 INDICATIONS AND USAGE SEVENFACT [coagulation factor VIIa (recombinant)-jncw] is indicated for the treatment and control of bleeding episodes occurring in adults and adolescents (12 years of age and older) with hemophilia A or B with inhibitors. Limitation of Use: SEVENFACT is not indicated for the treatment of patients with congenital Factor VII deficiency. SEVENFACT [coagulation factor VIIa (recombinant)-jncw] is a coagulation factor VIIa concentrate indicated for the treatment and control of bleeding episodes occurring in adults and adolescents (12 years of age and older) with hemophilia A or B with inhibitors ( 1 ). Limitation of Use: SEVENFACT is not indicated for treatment of congenital factor VII deficiency.

References: https://open.fda.gov/